Ki‐67 immunostaining and survival in operable lung cancer

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Histopathology

• Publication date

  1991-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2559.1991.tb01503.xPMID 1664810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer.

  1991cited by this paper
• Monoclonal antibody Ki‐67: its use in histopathology

  1990cited by this paper
• Lung cancer--still a long road ahead.

  1990cited by this paper
• Review: assessment of cell proliferation in histological material.

  1990cited by this paper
• Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling.

  1990cited by this paper
• Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research.

  1990cited by this paper
• Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.

  1990cited by this paper
• Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival.

  1989cited by this paper
• Lung cancer--a worldwide health problem.

  1989cited by this paper
• Prostaglandin E1: not the magic bullet in ARDS.

  1989cited by this paper
• Chemotherapy in lung cancer.

  1989cited by this paper
• DNA and S-phase distribution and incidence of metastasis in human primary lung carcinoma.

  1988cited by this paper
• Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

  1988cited by this paper
• Relationship between labeling indices of KI‐67 and brdurd in human malignant tumors

  1988cited by this paper
• Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.

  1988cited by this paper
• A new international staging system for lung cancer.

  1987cited by this paper
• Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody.

  1987cited by this paper
• New approach to assessing lung tumours in man.

  1986cited by this paper
• Survival in small cell lung carcinoma after surgery.

  1986cited by this paper
• Effect of initial resection of small-cell carcinoma of the lung: a review of Southwest Oncology Group Study 7628.

  1985cited by this paper
• Separation of small-cell from non-small-cell lung cancer. The Southeastern Cancer Study Group pathologists' experience.

  1984cited by this paper
• Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung

  1984cited by this paper
• Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group

  1984cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

  1983cited by this paper
• Bronchogenic carcinoma: Survival after surgical treatment according to stage, histologic type and immunomorphologic changes in regional lymph nodes

  1981cited by this paper
• Lung Cancer: Clinical Diagnosis and Treatment

  1978cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• [Chemotherapy of lung cancer].

  1972cited by this paper
• Bronchial Carcinoma

  1960cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• [Cancer of the lung].

  1952cited by this paper

• Epithelial cell size dysregulation in human lung adenocarcinoma

  2022cites this paper
• Analysis of lesion location and disease characteristics of pharyngeal and laryngeal papilloma in adult

  2022cites this paper
• A Case of Carcinoid Tumors in the Ear Canal With Long-Term Postoperative Follow-Up

  2021cites this paper
• Squamous cell carcinoma of the esophagus

  2020cites this paper
• rebrin : A new oncofetal biomarker associated with prognosis of lung denocarcinoma

  2016cites this paper
• Equine Endometrial Development: Setting the Stage for Reproductive Success

  2016cites this paper
• Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma.

  2016cites this paper
• Rare idiopathic interstitial pneumonias: LIP and PPFE and rare histologic patterns of interstitial pneumonias: AFOP and BPIP

  2016cites this paper
• The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma

  2015cites this paper
• Carcinoid tumor of the middle ear: a case report and review of literature.

  2014cites this paper
• p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival

  2014cites this paper
• Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.

  2013cites this paper
• Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer.

  2012cites this paper
• Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors

  2012cites this paper
• p53-Alterationen in Kolonadenomen: Beziehung zu Zellproliferation und Klinik

  2011cites this paper
• Chapter 12 - Tumours

  2011cites this paper
• Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas.

  2011cites this paper
• Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.

  2010cites this paper
• Surgical Treatment by Partial Petrosectomy for a Middle-Ear Carcinoid with Progressive Extension: A Case Report and Review of the Literature

  2010cites this paper
• Correlation of metallothionein expression with clinical progression of cancer in the oral cavity.

  2009cites this paper
• A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy

  2007cites this paper
• Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer

  2006cites this paper
• Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma.

  2006cites this paper
• Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer

  2005cites this paper
• EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients.

  2005cites this paper
• Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact.

  2005cites this paper
• Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy

  2004cites this paper
• Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers

  2004cites this paper
• Aus der Radiologischen Universitätsklinik Tübingen

  2004cites this paper
• Proliferationsaktivität, p53-Expression und Angiogenese bei pulmonalen Karzinomsarkomen und Pulmoblastomen

  2004cites this paper
• Detection of mutations in the cDNA of the proliferation marker Ki-67 protein in four tumor cell lines.

  2004cites this paper
• Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

  2004influential citation
• Laminin, Her2/neu and Ki-67 as prognostic factors in non-small cell lung cancer.

  2004cites this paper
• Prognosis of Patients Correlated with Markers of Hypoxia / Acidity and with Poor Tumor-associated Stroma of Non-Small Cell Lung Cancer Is Enhanced Expression of SPARC / Osteonectin in the Updated Version

  2003cites this paper
• Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma

  2003influential citation
• Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.

  2003cites this paper
• Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.

  2003cites this paper
• Prognostic Relevance of Ki-67 Antigen Expression in 329 Cases of Oral Squamous Cell Carcinoma

  2002cites this paper
• Genetic and Molecular Coordinates of Neuroendocrine Lung Tumors, with Emphasis on Small-cell Lung Carcinomas

  2002cites this paper
• Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung.

  2002cites this paper
• Requisitos mínimos para o laudo de anatomia patológica em câncer de pulmão: justificativas na patogênese *

  2002cites this paper
• Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.

  2001cites this paper
• Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients.

  2001influential citation
• Expression of exon 13 from the Ki-67 gene in human cells and tissues by digoxigenin-labelled mRNA in situ hybridization.

  2001cites this paper
• Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.

  2001cites this paper
• Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

  2001cites this paper
• Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)

  2001cites this paper
• Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung

  2001cites this paper
• Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas.

  2001cites this paper
• Ki‐67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma

  2000cites this paper
• Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.

  2000cites this paper
• Overexpression of CDC 25 B Phosphatase as a Novel Marker of Poor Prognosis of Human Colorectal Carcinoma 1

  2000cites this paper
• Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity

  2000cites this paper
• Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma.

  2000cites this paper
• Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.

  2000cites this paper
• Altered Expression of the Cell Cycle Regulatory Molecules pRb, p53 and MDM2 Exert a Synergetic Effect on Tumor Growth and Chromosomal Instability in Non-small Cell Lung Carcinomas (NSCLCs)

  2000cites this paper
• c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.

  2000cites this paper
• Relationship between cancer cell proliferation and thallium-201 uptake in lung cancer

  2000cites this paper
• Advances in Brief Overexpression of Cyclin B 1 in Early-Stage Non-Small Cell Lung Cancer and Its Clinical Implication 1

  2000cites this paper
• Prognostic value of cytokinetic parameters in lung cancer after in vivo bromodeoxyuridine labelling.

  1999cites this paper
• Nuclear localization of human AP endonuclease 1 (HAP1/Ref‐1) associates with prognosis in early operable non‐small cell lung cancer (NSCLC)

  1999cites this paper
• p53 and P-glycoprotein expression do not correlate with survival in nonsmall cell lung cancer: a long-term study and literature review.

  1999cites this paper
• [Biological perspectives].

  1998cites this paper
• Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer.

  1998cites this paper
• Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer.

  1998cites this paper
• The predictive value of p53, MDM-2, cyclin D1 and Ki67 in the progression from low-grade dysplasia towards carcinoma of the larynx

  1998cites this paper
• Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.

  1998cites this paper
• Role of p27 Kip1 and Cyclin-Dependent Kinase 2 in the Proliferation of Non-Small Cell Lung Cancer

  1998cites this paper
• Predicting prognosis in lung cancer: use of proliferation marker, Ki67 monoclonal antibody.

  1998cites this paper
• Prognosis in lower lip squamous cell carcinoma: assessment of tumor factors.

  1998cites this paper
• The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.

  1998cites this paper
• MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.

  1998cites this paper
• Non-small cell lung cancer: clinical value of new biological predictors

  1997cites this paper
• The prognostic significance of p53 and bcl‐2 expression in lung adenocarcinoma and its correlation with ki‐67 growth fraction

  1997cites this paper
• DNA Aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma

  1997cites this paper
• Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

  1997cites this paper
• Potential role of bcl‐2 as a suppressor of tumour angiogenesis in non‐small‐cell lung cancer

  1997cites this paper
• Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.

  1997cites this paper
• Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung.

  1997cites this paper
• Ki‐67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas

  1997cites this paper
• Proliferative activity and p53 protein accumulation correlate with early invasive trend, and apoptosis correlates with differentiation grade in oesophageal squamous cell carcinomas

  1997cites this paper
• Non-small cell lung cancer: clinical value of new biological predictors.

  1997cites this paper
• C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.

  1996cites this paper
• Proliferation markers and their uses in the study of endocrine tumors

  1996cites this paper
• Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study.

  1996cites this paper
• Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinoma.

  1996cites this paper
• The proliferation index of MIB‐1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract

  1996cites this paper
• Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation.

  1996cites this paper
• In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas

  1996cites this paper
• PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON‐SMALL CELL LUNG CANCER

  1996cites this paper
• Comparison of DNA topoisomerase IIα expression in small cell and nonsmall cell carcinoma of the lung: In search of a mechanism of chemotherapeutic response

  1996cites this paper
• Combined Analysis of Expression of c‐evbB‐2, Ki‐67 Antigen, and Tenascin Provides a Better Prognostic Indicator of Carcinoma of the Papilla of Vater

  1996cites this paper
• Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.

  1996cites this paper
• P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer.

  1996cites this paper
• Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.

  1996cites this paper
• [Proliferation kinetics of bronchioloalveolar tumorlets].

  1996cites this paper
• PROGNOSTIC VALUE OF MIB‐1 IN NEUROENDOCRINE TUMOURS OF THE LUNG

  1996cites this paper
• Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars.

  1995cites this paper
• Biological prognostic factors in non-small cell lung cancer.

  1995cites this paper
• Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.

  1995cites this paper